BCM
MTCR

BML Capital Management’s Metacrine, Inc. Common Stock MTCR Stock Holding History

BML Capital Management’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,167,458
Closed -$3.52M – 37
2023
Q1 		$3.52M Hold
6,167,458
– – 3.04% 15
2022
Q4 		$2.76M Buy
+6,167,458
New +$2.55M 2.64% 12

BML Capital Management's MTCR Position: Q2 2023 in Review

BML Capital Management sold out of Metacrine, Inc. Common Stock (MTCR) in Q2 2023, closing a stake of 6,167,458 shares — an estimated $3.52M sold.

BML Capital Management first reported a position in MTCR in Q4 2022 and held it in 2 quarters. The position peaked at $3.52M in Q1 2023. 0 funds tracked by Wall St. Rank hold MTCR as of Q2 2023.

  • BML Capital Management reported no remaining Metacrine, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • BML Capital Management sold 6,167,458 Metacrine, Inc. Common Stock shares in Q2 2023, an estimated $3.52M.
  • BML Capital Management first reported a position in Metacrine, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • BML Capital Management's Metacrine, Inc. Common Stock position peaked at $3.52M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q2 2023.

Based on BML Capital Management's 13F filing for Q2 2023, filed 24 Jul 2023.